Mission

PharmAthene’s mission is to become the premier company worldwide specializing in the development and rapid commercialization of best-in-class medical countermeasures for the multi-billion dollar biodefense industry.  By following a strategy of acquiring leading compounds and technologies focused only on high priority medical countermeasures solutions identified by the United States and other governments as urgent to procure, PharmAthene has built a solid product pipeline and a strong reputation within the industry.  To date, the Company has been awarded up to more than $550 million in United States government contract and funding commitments to support its product development programs.